Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Melanoma Management|November 22, 2018
Combatting mucosal melanoma: recent advances and future perspectivesHelen Tyrrell, Miranda Payne
Biochemical Society Transactions|May 16, 2009
Genomic instability and cancer: lessons from analysis of Bloom's syndromeMiranda Payne, Ian D Hickson
Rheumatology (Oxford, England)|December 10, 2019
Toxicities associated with checkpoint inhibitors-an overviewLaura Spiers, Nicholas Coupe, Miranda Payne
European Journal of Cancer Care|March 29, 2022
Implications of systemic adjuvant melanoma treatments for U.K. melanoma services: Results of the U.K. Melanoma Adjuvant Pathway SurveyOliver Cassell, Catherine Harwood, Melanie Hovey, et al.
Advances in Therapy|March 29, 2021
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy VolunteersHelen Tyrrell, Renato Ravanello, Jennifer Pulley, et al.
Advances in Therapy|May 24, 2020
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical ProgramWilliam J Sandborn, Severine Vermeire, Helen Tyrrell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trialMiranda Payne, Paul Ellis, David Dunlop, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2009
Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancerMiranda Payne, Penny Bradbury, Bethan Lang, et al.
Therapeutic Advances in Medical Oncology|November 7, 2022
Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanomaRicky Frazer, Avinash Gupta, Christopher Herbert, et al.
Pageof 4